1
|
Thomsen RS, Nilsen TIL, Haugeberg G, Bye A, Kavanaugh A, Hoff M. Effect of high-intensity interval training on cardiovascular disease risk factors and body composition in psoriatic arthritis: a randomised controlled trial. RMD Open 2018; 4:e000729. [PMID: 30402265 PMCID: PMC6203095 DOI: 10.1136/rmdopen-2018-000729] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2018] [Revised: 07/18/2018] [Accepted: 09/09/2018] [Indexed: 01/13/2023] Open
Abstract
Background Psoriatic arthritis (PsA) is associated with an accumulation of cardiovascular disease (CVD) risk factors. The aim of this study was to evaluate the effect of high-intensity interval training (HIIT) on CVD risk factors in patients with PsA. Methods We randomly assigned 61 patients with PsA (41 women and 20 men) to an intervention group performing HIIT for 11 weeks or a control group who were instructed to not change their physical exercise habits. Outcomes were assessed at 3 and 9 months with measures on maximal oxygen uptake (VO2max), fat percentage and Body Mass Index (BMI). We used linear mixed models to calculate mean difference with 95% CI between the groups according to the intention-to-treat principle. Results At 3 months, the HIIT group had a 3.72 mL/kg/min (95% CI 2.38 to 5.06) higher VO2max and a 1.28 (95% CI −2.51 to −0.05) lower truncal fat percentage than controls. There was also some evidence that the HIIT group had lower total fat percentage (−0.80; 95% CI −1.71 to 0.10) and slightly lower BMI (−0.31; 95% CI −0.78 to 0.17) than the control group. At 9 months, the HIIT group had still a higher VO2max (3.08; 95% CI 1.63 to 4.53) than the control group, whereas the difference in other factors were small. Conclusion In patients with PsA, 3 months with HIIT was associated with a substantial increase in VO2max and a reduction in truncal fat percentage compared with controls. The beneficial effect on VO2max was also sustained through 9 months. Trial registration number NCT02995460.
Collapse
Affiliation(s)
- Ruth Stoklund Thomsen
- Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.,Department of Rheumatology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
| | - Tom Ivar Lund Nilsen
- Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.,Department of Anaesthesia and Intensive Care, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
| | - Glenn Haugeberg
- Department of Neuromedicine and Movement Science, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.,Division of Rheumatology, Department of Medicine, Hospital of Southern Norway Trust, Kristiansand, Norway
| | - Anja Bye
- Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.,St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
| | - Arthur Kavanaugh
- Division of Rheumatology, Allergy, and Immunology, School of Medicine, University of California, San Diego, California, USA
| | - Mari Hoff
- Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.,Department of Rheumatology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.,Department of Neuromedicine and Movement Science, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
| |
Collapse
|
2
|
Bea JW, Hsu CH, Blew RM, Irving AP, Caan BJ, Kwan ML, Abraham I, Going SB. Use of iDXA spine scans to evaluate total and visceral abdominal fat. Am J Hum Biol 2017; 30. [PMID: 28884861 DOI: 10.1002/ajhb.23057] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Revised: 06/30/2017] [Accepted: 08/24/2017] [Indexed: 01/01/2023] Open
Abstract
OBJECTIVES Abdominal fat may be a better predictor than body mass index (BMI) for risk of metabolically-related diseases, such as diabetes, cardiovascular disease, and some cancers. We sought to validate the percent fat reported on dual energy X-ray absorptiometry (DXA) regional spine scans (spine fat fraction, SFF) against abdominal fat obtained from total body scans using the iDXA machine (General Electric, Madison, WI), as previously done on the Prodigy model. METHODS Total body scans and regional spine scans were completed on the same day (N = 50). In alignment with the Prodigy-based study, the following regions of interest (ROI) were assessed from total body scans and compared to the SFF from regional spine scans: total abdominal fat at (1) lumbar vertebrae L2-L4 and (2) L2-Iliac Crest (L2-IC); (3) total trunk fat; and (4) visceral fat in the android region. Separate linear regression models were used to predict each total body scan ROI from SFF; models were validated by bootstrapping. RESULTS The sample was 84% female, a mean age of 38.5 ± 17.4 years, and mean BMI of 23.0 ± 3.8 kg/m2 . The SFF, adjusted for BMI, predicted L2-L4 and L2-IC total abdominal fat (%; Adj. R2 : 0.90) and total trunk fat (%; Adj. R2 : 0.88) well; visceral fat (%) adjusted R2 was 0.83. Linear regression models adjusted for additional participant characteristics resulted in similar adjusted R2 values. CONCLUSIONS This replication of the strong correlation between SFF and abdominal fat measures on the iDXA in a new population confirms the previous Prodigy model findings and improves generalizability.
Collapse
Affiliation(s)
- J W Bea
- University of Arizona Cancer Center, Tucson, Arizona 85724-5024.,Department of Medicine, College of Medicine, University of Arizona, Tucson, Arizona 85724-5024.,Department of Nutritional Sciences, University of Arizona, Tucson, Arizona 85721.,The Collaboratory for Metabolic Disease Prevention and Treatment, University of Arizona, Tucson, Arizona 85714
| | - C-H Hsu
- Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona 85724
| | - R M Blew
- Department of Nutritional Sciences, University of Arizona, Tucson, Arizona 85721.,The Collaboratory for Metabolic Disease Prevention and Treatment, University of Arizona, Tucson, Arizona 85714
| | - A P Irving
- University of Arizona Cancer Center, Tucson, Arizona 85724-5024.,Department of Nutritional Sciences, University of Arizona, Tucson, Arizona 85721
| | - B J Caan
- Division of Research, Kaiser Permanente Northern California, Oakland, California 94612
| | - M L Kwan
- Division of Research, Kaiser Permanente Northern California, Oakland, California 94612
| | - I Abraham
- University of Arizona Cancer Center, Tucson, Arizona 85724-5024.,Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, Arizona 85721
| | - S B Going
- Department of Nutritional Sciences, University of Arizona, Tucson, Arizona 85721.,The Collaboratory for Metabolic Disease Prevention and Treatment, University of Arizona, Tucson, Arizona 85714
| |
Collapse
|